Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 55: 568-572, 2009. First published January 23, 2009; 10.1373/clinchem.2008.112425
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2008.112425v1
55/3/568    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, D.
Right arrow Articles by von Eynatten, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, D.
Right arrow Articles by von Eynatten, M.
(Clinical Chemistry. 2009;55:568-572.)
© 2009 American Association for Clinical Chemistry, Inc.

Brief Communications

Comparison of Immunoassays for the Selective Measurement of Human High–Molecular Weight Adiponectin

Dan Liu1,2, Tibor Schuster3, Marcus Baumann1, Marcel Roos1, Daniel Sollinger1, Jens Lutz1, Uwe Heemann1 and Maximilian von Eynatten1,a

1 Department of Nephrology, Technische Universitaet Muenchen, Munich, Germany; 2 Department of Endocrinology, the Second Hospital of Sun Yat-Sen University, Guangzhou, Peoples Republic of China; 3 Institute of Medical Statistics and Epidemiology, Technische Universitaet Muenchen Ismaningerstr. Munich, Germany;

aaddress correspondence to this author at: Maximilian von Eynatten, Department of Nephrology, Technische Universitaet Muenchen, Ismaningerstr. 22, 81675 Munich, Germany. Fax +49-89-4140-4741; e-mail maximilian.eynatten{at}lrz.tum.de.


Abstract

Background: Adiponectin is an adipocyte-derived hormone circulating in different multimer complexes. The high–molecular-weight (HMW) complex is likely the active form of this protein and has been recognized as a risk marker for type 2 diabetes and coronary artery disease (CAD). Because quantification of HMW adiponectin by Western blot analysis is time-consuming, novel ELISAs have been developed to simplify measurements in clinical research. However, these enzyme immunoassays have not been cross-validated in larger patient groups. We evaluated 2 individual ELISA systems by comparison to Western blotting for measurement of the distribution of HMW adiponectin in healthy individuals and patients with CAD and type 2 diabetes.

Methods: We measured HMW adiponectin in 204 individuals (83 CAD patients, 81 type 2 diabetes patients, and 40 healthy controls). Correlations, range of agreement, and imprecision of HMW concentrations obtained using 2 commercial ELISAs (#1, ALPCO Diagnostics; #2, Millipore) were evaluated by comparison with quantitative Western blotting.

Result: Adiponectin results of the ELISAs were significantly correlated with those obtained by Western blotting (both r > 0.75, P < 0.001). Deming regression and Bland-Altman analyses indicated high agreement among the 3 immunoassays. The median difference between HMW adiponectin concentrations measured by ELISA and by Western blot was +0.4 mg/L for ELISA #1 and –0.4 mg/L for ELISA #2 with 95% of value differences <3 mg/L.

Conclusions: Selective measurement of HMW adiponectin by ELISA is feasible; however, individual differences among immunoassays must be considered. The evaluated ELISAs exhibit analytical characteristics that allow their use as equivalent for Western blot analysis in larger clinical and epidemiological groups.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the American Association for Clinical Chemistry.